Blog Posts

Arizona Republican Introduces 340B Contract Pharmacy Bill, Draws Dark Money Opposition

A photo of the Arizona state capitol
An Arizona state representative recently introduced a bill prohibiting manufacturers from restricting 340B contract pharmacy access.
An Arizona state Republican recently introduced a 340B contract pharmacy access bill—and he has already drawn the ire of a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Kansas Introduces 340B Hospital Reporting Bill Amid Stalled Contract Pharmacy Legislation 

The Kansas state capitol.
A Kansas House committee recently introduced legislation requiring state hospitals to annually report on their 340B programs.
Kansas House lawmakers recently introduced a 340B hospital reporting bill—while a separate Senate-approved 340B contract pharmacy access bill remains stalled [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

HHS Releases New Guidance for Direct-to-Consumer Drug Sales

A screenshot of the HHS OIG's Jan. 27 bulletin on direct-to-consumer sales.
The HHS Office of Inspector General published a Jan. 27 bulletin detailing how drugmakers can take advantage of direct-to-consumer sales to patients with federal health care coverage.
Pharmaceutical manufacturers can sell prescription drugs directly to patients—including Medicare and Medicaid enrollees—who choose to pay with cash as long [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

State Contract Pharmacy Roundup: Actions in Utah, Maine, New Mexico and Oregon

A lawyer writes
Lawsuits against contract pharmacies saw movement in Utah, Maine, New Mexico and Oregon.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Expert Tip

Expert Tip from Ravin Consultants

img

TIP: Make your FQHC’s 340B pharmacy access visible by consistently communicating low-cost medication options at scheduling, intake, and care coordination touchpoints.

Read More »

Large Hospital Group Asks HRSA to Immediately Block Lilly’s 340B In-House Pharmacy Claims Data Policy

A screenshot of AHA's Jan. 26 letter to HRSA
The American Hospital Association urged HRSA to take enforcement action against Eli Lilly's new 340B claims data policy.
The American Hospital Association (AHA) on Monday asked federal regulators to “take any and all available enforcement action” to halt [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Lobbying Remained Strong in Final Quarter of 2025, Disclosure Filings Show

A chart showing "340B" lobbying filings made in each quarter of 2025.
More than 310 firms listed the 340B program in their fourth quarter lobbying disclosure forms that were due Jan. 20.
The 340B program continued to draw heavy lobbying attention on Capitol Hill in the final months of 2025, as a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Industry Insights Logo

Rebate Model Myths — and Facts!

SPONSORED CONTENT

Myth: Because the rebate model didn’t go live on January 1, there were no changes January 1 for entities.

While the rebate model is on pause, working its way through

Read More »

State 340B Contract Pharmacy Access Bills Move in Washington, Iowa

A photo of the Washington state capitol next to the Iowa state capitol.
Washington and Iowa state lawmakers recently advanced 340B contract pharmacy access bills.
Bills prohibiting drugmaker 340B contract pharmacy restrictions recently advanced in both Washington state and Iowa, signaling early momentum for contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Three Drugmakers To Refund 340B Covered Entities for Overcharges, Two Announce NDC Changes  

A screenshot of the manufacturer notices on the Health Resources and Services Administration’s Office of Pharmacy Affairs website.
UCB, Johnson & Johnson and Baxter notified covered entities of refunds, while Baxter and Amgen announced new National Drug Codes for certain products.
Three drugmakers recently announced refunds to 340B covered entities that purchased certain medications between 2008 and 2023, while two unveiled [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live